Genetic compensation induced by deleterious mutations but not gene knockdowns
暂无分享,去创建一个
[1] H. Stefánsson,et al. Identification of a large set of rare complete human knockouts , 2015, Nature Genetics.
[2] M. Estelle,et al. Auxin binding protein 1 (ABP1) is not required for either auxin signaling or Arabidopsis development , 2015, Proceedings of the National Academy of Sciences.
[3] Zacharias Kontarakis,et al. Making sense of anti-sense data. , 2015, Developmental cell.
[4] C. Betsholtz,et al. Reverse genetic screening reveals poor correlation between morpholino-induced and mutant phenotypes in zebrafish. , 2015, Developmental cell.
[5] T. Sargent,et al. The Serine-Threonine Protein Kinase PAK4 Is Dispensable in Zebrafish: Identification of a Morpholino-Generated Pseudophenotype , 2014, PloS one.
[6] M. Krüger,et al. Global protein expression profiling of zebrafish organs based on in vivo incorporation of stable isotopes. , 2014, Journal of proteome research.
[7] Xuejun Li,et al. VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro. , 2014, International journal of clinical and experimental pathology.
[8] Erin L. Doyle,et al. TAL Effector Specificity for base 0 of the DNA Target Is Altered in a Complex, Effector- and Assay-Dependent Manner by Substitutions for the Tryptophan in Cryptic Repeat –1 , 2013, PloS one.
[9] Luke A. Gilbert,et al. CRISPR interference (CRISPRi) for sequence-specific control of gene expression , 2013, Nature Protocols.
[10] Susan R. Wente,et al. Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system , 2013, Proceedings of the National Academy of Sciences.
[11] F. Conlon,et al. CASZ1 promotes vascular assembly and morphogenesis through the direct regulation of an EGFL7/RhoA-mediated pathway. , 2013, Developmental cell.
[12] P. Riley,et al. Thymosin β4 in vascular development response to research commentary. , 2013, Circulation research.
[13] D. Westaway,et al. Knockout of the prion protein (PrP)-like Sprn gene does not produce embryonic lethality in combination with PrPC-deficiency , 2012, Proceedings of the National Academy of Sciences.
[14] H. Stuhlmann,et al. EGFL7: a unique angiogenic signaling factor in vascular development and disease. , 2012, Blood.
[15] Erin L. Doyle,et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting , 2011, Nucleic acids research.
[16] M. Mann,et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.
[17] K. Stankunas,et al. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126 , 2008, Development.
[18] M. Mann,et al. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.
[19] F. Soncin,et al. VE‐statin/egfl7 regulates vascular elastogenesis by interacting with lysyl oxidases , 2008, The EMBO journal.
[20] Guson Kang,et al. Foxn4 directly regulates tbx2b expression and atrioventricular canal formation. , 2008, Genes & development.
[21] I. Kasman,et al. EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution , 2007, Development.
[22] C. Brenner,et al. p53 Activation by Knockdown Technologies , 2007, PLoS genetics.
[23] Yudong D. He,et al. Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice , 2006, Nucleic acids research.
[24] D. Stainier,et al. Cellular and molecular analyses of vascular tube and lumen formation in zebrafish , 2005, Development.
[25] Didier Y. R. Stainier,et al. The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation , 2004, Nature.
[26] P. Braghetta,et al. EMILIN-1 Deficiency Induces Elastogenesis and Vascular Cell Defects , 2004, Molecular and Cellular Biology.
[27] Christine Brun,et al. In silico prediction of protein-protein interactions in human macrophages , 2001, BMC Research Notes.
[28] RNA interference on target , 2006, Nature Methods.